We are seeking a CDMO partner for a clinical sterile fill–finish project involving tirzepatide injection in 5 mL vials using a standard container-closure system, intended for EU clinical trial use. The scope includes aseptic/sterile fill–finish of 3,000 vials suitable for clinical supply. Please let us know your capability, indicative timelines, and requirements to initiate a feasibility assessment. Further technical details can be shared under CDA.